Dat
Payments companies reported to CMS as associated with Dat. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dat, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dat
These are the largest totals companies reported as associated with Dat. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Julie Yang | Pasadena, CA | Gastroenterology (Internal Medicine) | $90.22 |
| Anthony Gamboa | Nashville, TN | Gastroenterology (Internal Medicine) | $32.67 |
| Mark Radlinski | Nashville, TN | Gastroenterology (Internal Medicine) | $32.67 |
| Nihaal Karnik | Seattle, WA | Gastroenterology (Internal Medicine) | $21.72 |
| Kishore Kumar | Scranton, PA | Gastroenterology (Internal Medicine) | $21.72 |
| Patrick Saitta | New York, NY | Gastroenterology (Internal Medicine) | $17.65 |
| Sammy Ho | Bronx, NY | Gastroenterology (Internal Medicine) | $13.39 |
| Stephanie Pointer | Nashville, TN | Gastroenterology (Internal Medicine) | $10.36 |
| Alfredo Chavez | El Paso, TX | Gastroenterology (Internal Medicine) | $9.80 |
| Orestes Moldes-Rodriguez | El Paso, TX | Gastroenterology (Internal Medicine) | $9.80 |
Prescribed Dat?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.